A Case of Erythema Elevatum Diutinum (EED) Exhibiting A Keloid-Like Appearance.
Abnormal scars
Erythema elevatum diutinum
Keloids
Nodules
Journal
Dermatology and therapy
ISSN: 2193-8210
Titre abrégé: Dermatol Ther (Heidelb)
Pays: Switzerland
ID NLM: 101590450
Informations de publication
Date de publication:
Dec 2021
Dec 2021
Historique:
received:
04
08
2021
accepted:
30
10
2021
pubmed:
16
11
2021
medline:
16
11
2021
entrez:
15
11
2021
Statut:
ppublish
Résumé
Most severe-appearing keloids tend to occur around joints because of the increased extensional stimulation of the scar in those areas. However, erythema elevatum diutinum (EED) appears more commonly on friction sites including extensor surfaces of the extremities and dorsal surfaces of joints. EEDs also presents as red-brown and elevated lesions. In this report, we describe a 42-year-old female who presented with firm, sporadic, brown-colored raised nodules on her bilateral lower extremities. As the appearance of these nodules resembled keloids, resection of the affected area with subsequent radiation therapy was initiated. However, histopathologic examination performed after treatment revealed tuberous lesions in the dermis, increased wired collagen fibers, neutrophilic infiltrate with nuclear dust, and edematous endothelial cells in the small vessels. Consequently, the patient was later diagnosed with EED. Post-surgery, no recurrence or abnormal scars appeared. Whereas clinical findings of EED are similar to that of keloids, the mechanisms of the two conditions differ considerably, leading to varying management strategies. EEDs can be misdiagnosed as keloids on several grounds; they can both appear morphologically similar, exhibit as stiff lesions, demonstrate chronic inflammation of the reticular dermis, and appear anywhere on the body. The only definitive method of differentiating between the two is through histopathologic examination. EED should be considered as one of the differential diagnoses for any patients presenting with keloid-like lesions on friction sites and biopsy should be performed prior to resection and radiotherapy.
Identifiants
pubmed: 34778936
doi: 10.1007/s13555-021-00639-0
pii: 10.1007/s13555-021-00639-0
pmc: PMC8611145
doi:
Types de publication
Journal Article
Langues
eng
Pagination
2235-2240Informations de copyright
© 2021. The Author(s).
Références
Berman B, Maderal A, Raphael B. Keloids and hypertrophic scars: pathophysiology, classification, and treatment. 2017;S3–18. https://doi.org/10.1097/DSS.0000000000000819
Sano H, Hokazono Y, Ogawa R. Distensibility and gross elasticity of the skin at various body sites and association with pathological scarring: a case study. J Clin Aesthetic Dermatol. 2018;11:15–8.
Sardina LA, Jour G, Piliang MP, Bergfeld WF. Erythema elevatum diutinum a rare and poorly understood cutaneous vasculitis: a single institution experience. J Cutan Pathol. 2019;46:97–101. https://doi.org/10.1111/cup.13378 .
doi: 10.1111/cup.13378
pubmed: 30362150
Momen SE, Jorizzo J, Al-Niaimi F. Erythema elevatum diutinum: a review of presentation and treatment. J Eur Acad Dermatol Venereol. 2014;28:1594–602. https://doi.org/10.1111/jdv.12566 .
doi: 10.1111/jdv.12566
pubmed: 25288365
Mancano VS, Dinato SLME, Almeida JRP, Romiti N. Erythema elevatum diutinum. An Bras Dermatol. 2018;93:614–5.
doi: 10.1590/abd1806-4841.20187470
Jumper N, Paus R, Bayat A. Functional histopathology of keloid disease. 2015;30:1033–57. https://doi.org/10.14670/HH-11-624
Bolognia JL, Braverman IM. Skin manifestations of internal disease. In: Jameson J, Fauci AS, Kasper DL, Hauser SL, Longo DL, Loscalzo J, editors. Harrison’s principles of internal medicine. 20th ed. McGraw Hill; 2018.
Ogawa R, Akaishi S, Kuribayashi S, Miyashita T. Keloids and hypertrophic scars can now be cured completely: recent progress in our understanding of the pathogenesis of keloids and hypertrophic scars and the most promising current therapeutic. Strategy. 2016;83:46–53. https://doi.org/10.1272/jnms.83.46 .
doi: 10.1272/jnms.83.46
Hutchinson J. On two remarkable cases of symmetrical purple congestion of the skin in patches, with induration. Br J Dermatol. 1880;1:10.
Wahl CE, Bouldin MB, Gibson LE. Erythema elevatum diutinum: clinical, histopathologic, and immunohistochemical characteristics of six patients. Am J Dermatopathol. 2005;27:397–400.
doi: 10.1097/01.dad.0000175526.89249.be
Ahmad S, Delarosa M, Kleinman W, Ahmad R. Primary surgical treatment of erythema elevatum diutinum. J Hand Surg. 2019;44:522.e1-522.e5.
doi: 10.1016/j.jhsa.2018.07.018
Ogawa R. Keloid and hypertrophic scars are the result of chronic inflammation in the reticular dermis. 2017;18. https://doi.org/10.3390/ijms18030606
Ogawa R, Akita S, Akaishi S, Aramaki-Hattori N, Dohi T, Hayashi T, et al. Diagnosis and treatment of keloids and hypertrophic scars-japan scar workshop consensus document 2018. 2019;7:39-019-0175-y. (eCollection 2019). https://doi.org/10.1186/s41038-019-0175-y
Ogawa R, Dohi T, Tosa M, Aoki M, Akaishi S. The Latest strategy for keloid and hypertrophic scar prevention and treatment: the Nippon Medical School (NMS) Protocol. 2021;88:2–9. https://doi.org/10.1272/jnms.JNMS.2021_88-106
Arno AI, Gauglitz GG, Barret JP, Jeschke MG. Up-to-date approach to manage keloids and hypertrophic scars: a useful guide. 2014;40:1255–66. https://doi.org/10.1016/j.burns.2014.02.011
Krishnan RS, Hwang LY, Tschen JA, Subrt P, Hsu S. Erythema elevatum diutinum mimicking extensive keloids; quiz 386. Cutis. 2001;67:381–5.
pubmed: 11381853